相关实验视频

Updated: Jan 16, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

研究SMR与乳腺癌相关蛋白质的相互作用

Ming-Bo Huang¹, Purushottam B Tiwari², Aykut Üren²

¹Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.

International journal of molecular sciences

|September 27, 2025

概括

艾滋病毒Nef蛋白的SMR结合Mortalin和Vimentin,这些蛋白质参与了乳腺癌 (BC) 的进展. 特定的Mortalin可以阻止这种相互作用,通过破坏瘤细胞过程来提供潜在的BC疗法.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
病毒学病毒学

背景情况:

乳腺癌 (BC) 仍然是癌症死亡的重要原因.
莫尔塔林和维门丁是参与BC进展和转移的蛋白质.
艾滋病毒Nef蛋白的分泌修饰区域 (SMR) 结合了Mortalin和Vimentin,可能会破坏外体细胞释放,并提供治疗点.

研究的目的:

为了研究SMR,Mortalin和Vimentin之间的结合相互作用.
绘制Mortalin上的SMR结合点的地图,并确定Vimentin上的类似点.
探索阻断乳腺癌中SMR-Mortalin/Vimentin相互作用的治疗潜力.

主要方法:

表面等离子体共振 (SPR) 用于量化结合亲和关系.
同免疫沉 (Co-IP) 证实BC细胞系中的相互作用.
西方斑点测定和扫描映射以确定结合部位和功能抑制.

主要成果:

完整的Nef蛋白对维门丁 (KD = 0.75 ± 1.1 nM) 和莫塔林 (KD = 3.16 ± 0.03 nM) 呈现出高亲和力.
该SMR与Mortalin和Vimentin结合,具有微分子亲和力 (KD=6.6320.73μM).
特定的Mortalin衍生 (#61和#62) 结合了SMR域,抑制了Nef活性,并阻止了SMRwt与Mortalin和Vimentin结合.

结论:

该SMR与Mortalin和Vimentin上特定的部位相互作用,可能破坏上皮层-介质细胞过渡 (EMT) 和瘤进展.
来自莫尔塔林的可以有效地阻止SMR与莫尔塔林和维丁的相互作用.
这些发现表明针对SMR相互作用的乳腺癌的新治疗策略.

关键词:

死亡和死亡是不同的.这是一种SMR.在Vimentin中,使用了Vimentin.蛋白相互作用蛋白相互作用表面等离子体共振 (SPR) 是一种表面等离子体共振.

更多相关视频

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...